ACZ885M
Biological
Novartis Pharma AG
Total Payments
$582,246
Transactions
99
Doctors
17
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $272,924 | 48 | 11 |
| 2017 | $309,323 | 51 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $376,614 | 15 | 64.7% |
| Consulting Fee | $117,768 | 28 | 20.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,695 | 1 | 8.7% |
| Travel and Lodging | $35,732 | 33 | 6.1% |
| Food and Beverage | $1,141 | 21 | 0.2% |
| Education | $295.93 | 1 | 0.1% |
Payments by Type
Research
$376,614
15 transactions
General
$205,632
84 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CACZ885M2301 | Novartis Pharma AG | $376,614 | 2 |
Top Doctors Receiving Payments for ACZ885M
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $257,937 | 3 |
| , MD | Internal Medicine | Detroit, MI | $101,276 | 5 |
| , M.D | Infectious Disease | Baltimore, MD | $68,096 | 8 |
| , M.D | Infectious Disease | Durham, NC | $62,381 | 15 |
| , MD | Cardiovascular Disease | Boston, MA | $27,199 | 23 |
| , MD | Internal Medicine | Houston, TX | $16,380 | 9 |
| , MD | Cardiovascular Disease | New York, NY | $13,118 | 7 |
| , MD | Cardiovascular Disease | Boston, MA | $6,979 | 6 |
| , M.D | Cardiovascular Disease | Durham, NC | $6,757 | 3 |
| , MD | Pediatric Rheumatology | Cincinnati, OH | $6,401 | 2 |
| , MD, DPHIL | Internal Medicine | Boston, MA | $4,930 | 2 |
| , MD | Rheumatology | Boston, MA | $4,380 | 2 |
| , M.D | Cardiovascular Disease | New York, NY | $2,438 | 4 |
| , MD, MPH | Cardiovascular Disease | Dallas, TX | $1,483 | 4 |
| , MD | Cardiovascular Disease | New York, NY | $1,211 | 2 |
| , DO | Cardiovascular Disease | Portland, OR | $1,211 | 2 |
| , MD | Cardiovascular Disease | Murray, UT | $35.00 | 1 |
| , MD | Cardiovascular Disease | Salt Lake City, UT | $35.00 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $582,246
Product Information
- Type Biological
- Total Payments $582,246
- Total Doctors 17
- Transactions 99
About ACZ885M
ACZ885M is a biological associated with $582,246 in payments to 17 healthcare providers, recorded across 99 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $272,924 was paid across 48 transactions to 11 doctors.
The most common payment nature for ACZ885M is "Unspecified" ($376,614, 64.7% of total).
ACZ885M is associated with 1 research study, including "CACZ885M2301" ($376,614).